CRIS Q3 2023 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$15M

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+0.3% YoY

Gross Profit

$3M97.9% margin

Operating Income

-$12M-436.6% margin

Net Income

-$12M-430.0% margin

EPS (Diluted)

$-2.13

QoQ Revenue Growth

+28.9%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$90M

Total Liabilities

$60M

Stockholders' Equity

$30M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	+0.3%
Gross Profit	$3M	$3M	+0.4%
Operating Income	-$12M	-$13M	+1.9%
Net Income	-$12M	-$13M	+8.4%

Revenue Segments

Gross Royalty Revenue

$3M100%